Representative Director and CEO of xFOREST, Shunichi Kashida, delivered a lecture at the 445th lecture meeting of the Chem-Bio Informatics Society (CBI Society) on the topic "Current state of the drug discovery venture ecosystem and the future vision of drug discovery visible from there".
(Japanese title: 創薬ベンチャーエコシステムの現状とそこから見える創薬の未来像)
Click here for related Links (CBI Society)
About xFOREST Therapeutics
xFOREST Therapeutics Co., Ltd. is a Kyoto-based biotechnology company engaged in the research and development of RNA-targeted small-molecule medicines. Building on its proprietary RNA structure analysis technology, xFOREST discovers selective small molecules for RNA targets that protein-first discovery cannot reach, and advances them into drug programs with partners.